Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Finasteride improves acne and hair loss in women with normal testosterone.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Fungal infections in lab animals can interfere with research.

Hair loss in black women needs more research, early intervention, and community education.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Stem cell differentiation is crucial for skin barrier maintenance and its disruption can lead to skin diseases.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Selenium sulfide in anti-dandruff shampoos can turn hair green.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Finasteride caused blisters on hands and feet.

Method measures latanoprost and minoxidil in skin accurately and precisely.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Skin health and diseases are closely linked to metabolic processes.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.